Cargando…

The Importance and Impact of Evidence Based medicine

Detalles Bibliográficos
Autores principales:	Lewis, Sonya J., Orland, Burton I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2004
Materias:	Cea
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437902/ https://www.ncbi.nlm.nih.gov/pubmed/15369418 http://dx.doi.org/10.18553/jmcp.2004.10.S5-A.S3

Ejemplares similares

Continuing Education
por: Carter, Barry L., et al.
Publicado: (2004)

Evidence Based Medicine Health Care's Next Holy War
por: Kleinke, J.D.
Publicado: (2005)

Evidence Based Health Benefits Management
por: Zabinski, Richard A.
Publicado: (2006)

Health Information Technology—Results From a Roundtable Discussion
por: Balfour, Donald C., et al.
Publicado: (2009)

The Future of Medicare Part D Drug Plans—Results From a Roundtable Discussion
por: Balfour III, Donald C., et al.
Publicado: (2009)

Disease Progression and the Application of Evidence-Based Treatment Guidelines Diagnose It Early: A Case for Screening and Appropriate Management
por: Manley, Harold J.
Publicado: (2007)

Importance of Blood Pressure Control Over a 24-Hour Period
por: White, William B.
Publicado: (2007)

Economic and Clinical Impact of Multiple Myeloma to Managed Care
por: Cook, Richard
Publicado: (2008)

Clinical, Economic, and Quality of Life Impact of Atrial Fibrillation
por: Sanoski, Cynthia A.
Publicado: (2009)

Part1 How the Emergence of Innovative Biologic Agents Impacts Benefit Design, Utilization, and Provider Relations
por: Lipsy, Robert J., et al.
Publicado: (2004)

Evidence for Long-Term Use of Intramuscular Interferon Beta-1a: An Overview of Relapse, Disability, and MRI Data from Selected Clinical Trials
por: Foley, John F., et al.
Publicado: (2013)

AHRQ's Effective Health Care Program: Its Impact on Managed Care
por: Fleming, William K.
Publicado: (2007)

The Impact of Residual Cardiovascular Risk in Combination Lipid-Modifying Therapy in the Managed Care Setting
por: Talbert, Robert L.
Publicado: (2008)

A Budget-Impact and Cost-Effectiveness Model for Second-Line Treatment of Major Depression
por: Malone, Daniel C.
Publicado: (2007)

Value-Based Benefit Design: Using a Predictive Modeling Approach to Improve Compliance
por: Mahoney, John J.
Publicado: (2008)

Implement Community Based Standards of Care
por: Urick, Paul N.
Publicado: (2005)

Performance-Based Measures: The Early Results Are In
por: O'Kane, Margaret E.
Publicado: (2007)

Introduction: Targeted Evidenced-Based Colorectal Cancer Therapies: Shifting the Patient Outcome
por: Minkoff, Neil B.
Publicado: (2007)

Introduction
por: Brixner, Diana I.
Publicado: (2012)

Introduction
por: Brixner, Diana I., et al.
Publicado: (2012)

Can CER Be an Effective Tool for Change in the Development and Assessment of New Drugs and Technologies?
por: Brixner, Diana I., et al.
Publicado: (2012)

Preview Overview
por: Lipsy, Robert J.
Publicado: (2004)

Statistical Issues with the Analysis of Nonrandomized Studies in Comparative Effectiveness Research
por: Alemayehu, Demissie, et al.
Publicado: (2011)

Developing a Collaborative Study Protocol for Combining Payer-Specific Data and Clinical Trials for CER
por: Sanchez, Robert J., et al.
Publicado: (2011)

Successful HIV Treatment
por: Cohen, Calvin J.
Publicado: (2006)

Introduction
por: Sax, Michael J.
Publicado: (2005)

Essential Steps and Practical Applications for Database Studies
por: Sax, Michael J.
Publicado: (2005)

Overview of Pharmacologic Therapy for the Treatment of Dyslipidemia
por: Lipsy, Robert J.
Publicado: (2003)

Introduction
por: Lipsy, Robert J.
Publicado: (2003)

Introduction
por: Cziraky, Mark J.
Publicado: (2008)

Not Getting to Goal: The Clinical Costs of Noncompliance
por: Ansell, Benjamin J.
Publicado: (2008)

Days of Prophylactic Filgrastim Use to Reduce Febrile Neutropenia in Patients
por: Scott, Shane J., et al.
Publicado: (2003)

Introduction
por: Mullins, C. Daniel, et al.
Publicado: (2011)

“Ten Commandments” for Conducting Comparative Effectiveness Research Using “Real-World Data”
por: Willke, Richard J., et al.
Publicado: (2011)

Considerations on the Use of Patient-Reported Outcomes in Comparative Effectiveness Research
por: Alemayehu, Demissie, et al.
Publicado: (2011)

Continuing Education
por: Lipsy, Robert J., et al.
Publicado: (2004)

Introduction
por: kleinke, J.D., et al.
Publicado: (2005)

Emerging Methods for Evaluating the Effectiveness of Intramuscular Interferon Beta-1a for Relapsing-Remitting Multiple Sclerosis
por: Foley, John F., et al.
Publicado: (2013)

Continuing Education
por: Chrischilles, Elizabeth A., et al.
Publicado: (2003)

Implementing the New Guidelines for Hypertension
por: Carter, Barry L.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_6ppe4pndbqtn376s5gc8gpac02